Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Yang, Kai Lin ^a   Yang, Shung Haur ^a,b   Liang, Wen Yih ^a,b   Kuo, Ying Ju ^a   Lin, Jen Kou ^a,b   Lin, Tzu Chen ^a   Chen, Wei Shone ^a,b   Jiang, Jeng Kae ^a,b   Wang, Huann Sheng ^a,b   Chang, Shih Ching ^a,b   Chu, Lee Shing ^a,b   Wang, Ling Wei ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Carcinoembryonic antigen; CEA ratio; Pre operative chemoradiation; Rectal cancer; Tumor response

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FOLINIC ACID; UFT; UFUR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; EXCISION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE RADIOTHERAPY; RADICAL PROCTECTOMY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TOTAL MESORECTAL EXCISION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TEGAFUR; TUMOR MARKERS, BIOLOGICAL; URACIL;

EID: 84874397354     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-43     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694, 15496622.
3. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625. 10.1200/JCO.2006.06.7629, 17008704.
4. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123. 10.1056/NEJMoa060829, 16971718.
5. Kao PS, Chang SC, Wang LW, Lee RC, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Lin JK. The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010, 102:771-777. 10.1002/jso.21711, 20872811.
6. Wang LW, Yang SH, Lin JK, Lin TC, Chan WK, Chen WS, Wang HS, Jiang JK, Lee RC, Li AF, Chao Y, Chi KH, Yen SH. Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol 2005, 89:256-263. discussion 263-254, 10.1002/jso.20168, 15726610.
7. Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, O'Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005, 47:141-146. 10.1111/j.1365-2559.2005.02176.x, 16045774.
8. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002, 94:1121-1130. 10.1002/cncr.10327, 11920483.
9. Bozzetti F, Andreola S, Bertario L. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1998, 13:54-55. 10.1007/s003840050134, 9548104.
10. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997, 12:19-23. 10.1007/s003840050072, 9112145.
11. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006, 24:5313-5327. 10.1200/JCO.2006.08.2644, 17060676.
12. Ishihara S, Watanabe T, Kiyomatsu T, Yasuda K, Nagawa H. Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. Int J Colorectal Dis 2010, 25:1417-1425. 10.1007/s00384-010-1051-1, 20809426.
13. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007, 109:1750-1755. 10.1002/cncr.22625, 17387743.
14. Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, Cho CW. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol 2006, 93:145-150. 10.1002/jso.20320, 16425302.
15. Yoon SM, Kim DY, Kim TH, Jung KH, Chang HJ, Koom WS, Lim SB, Choi HS, Jeong SY, Park JG. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007, 69:1167-1172. 10.1016/j.ijrobp.2007.04.047, 17967307.
16. Kim CW, Yu CS, Yang SS, Kim KH, Yoon YS, Yoon SN, Lim SB, Kim JC. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2011, 18:3271-3277. 10.1245/s10434-011-1740-1, 21537868.
17. Kouri M, Pyrhonen S, Mecklin JP, Jarvinen H, Laasonen A, Franssila K, Nordling S. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990, 62:976-981. 10.1038/bjc.1990.420, 1971551, 2257229.
18. Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2012, 83:1113-1119. 10.1016/j.ijrobp.2011.09.030, 22172905.
19. Perez RO, Sao Juliao GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum 2009, 52:1137-1143. 10.1007/DCR.0b013e31819ef76b, 19581858.
20. Park JW, Lim SB, Kim DY, Jung KH, Hong YS, Chang HJ, Choi HS, Jeong SY. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys 2009, 74:810-817. 10.1016/j.ijrobp.2008.08.057, 19101093.
21. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 2004, 60:1098-1105. 10.1016/j.ijrobp.2004.04.062, 15519780.